MORGAN STANLEY PLC/CALL/MERCK & CO./165/0.1/20.09.24 Stock

Warrant

DE000ME8HED3

Market Closed - Bid/Ask 12:49:24 2024-05-17 pm EDT After market 03:24:15 pm
0.029 EUR -9.38% Intraday chart for MORGAN STANLEY PLC/CALL/MERCK & CO./165/0.1/20.09.24 0.035 +20.69%
Current month-23.81%
1 month-34.69%
Date Price Change
24-05-17 0.029 -9.38%
24-05-16 0.032 -3.03%
24-05-15 0.033 +3.13%
24-05-14 0.032 -5.88%
24-05-13 0.034 -2.86%

Delayed Quote Börse Stuttgart

Last update May 17, 2024 at 12:49 pm EDT

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellCALL
Underlying MERCK & CO., INC.
Issuer Morgan Stanley
WKN ME8HED
ISINDE000ME8HED3
Date issued 2024-02-09
Strike 165 $
Maturity 2024-09-20 (126 Days)
Parity 10 : 1
Emission price 0.08
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 0.097
Lowest since issue 0.012
Spread 0.011
Spread %27.50%

Company Profile

Merck & Co., Inc. specializes in the development, production, and marketing of therapeutic products and vaccines sold under prescription. Net sales break down by activity as follows: - sale of pharmaceutical products (69.7%): for treating hypertension, osteoporosis, atherosclerosis, respiratory, bacterial and fungal, ophthalmologic, and urological diseases, acute migraine, hair loss in men, etc.; - sale of vaccines (18%); - sale of animal health products (9.4%); - other (2.9%). Net sales are distributed geographically as follows: the United States (45.9%), Europe/Middle East/Africa (24.5%), China (8.8%), Japan (6.1%), Asia/Pacific (6.1%), Latin America (4.3%) and other (4.3%).
Sector
-
More about the company

Ratings for Merck & Co., Inc.

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: Merck & Co., Inc.

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
130.9 USD
Average target price
141.6 USD
Spread / Average Target
+8.22%
Consensus
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW